KX-826 scalp solution for male pattern baldness
Part of Skin clinical trials.
This trial tests a once-daily scalp solution called KX-826 to help men with typical male pattern baldness grow hair and slow hair loss. It compares the active solution to a placebo (no active ingredient) to see if it works and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 49 years old
- You have male pattern baldness (a receding hairline or thinning crown)
- Your hair loss is rated IIIv, IV, or V on the Norwood Hamilton scale (moderate hair loss with a balding spot on top)
- You are willing to get a small ink dot tattoo on your scalp to mark the area being treated
- You will keep the same hairstyle, length, and color at every visit
- You commit to using effective birth control during the study and for 3 months after the last dose
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called OLX72021 for male pattern hair loss (androgenetic alopecia). It aims to see if the drug is safe and effective in healthy men with mild to moderate hair loss.
This trial tests a new medication called ABS-201 for hair loss. It will first see if the medicine is safe in healthy people, then test if it helps those with male or female pattern baldness.
This trial tests a new oral (pill) form of minoxidil to help regrow hair in men with male-pattern baldness. Minoxidil is a known hair-growth medication, and this study evaluates whether taking it as a pill works safely and effectively.
This research study examines what causes male pattern baldness (androgenetic alopecia) by studying hair, skin, and biological samples from men with hair loss and healthy men. The goal is to better understand why hair loss happens so scientists can develop better treatments.
This trial tests whether a low-dose oral form of minoxidil (a common hair-loss medicine) can help people with mild to severe male or female pattern baldness.
This trial tests an experimental tablet for teenagers with severe alopecia areata, a condition causing patchy hair loss. The treatment may help regrow hair with clearer information about safety and effectiveness.
Hear when a new Androgenetic Alopecia (AGA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.